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Amyotrophic lateral sclerosis (ALS) is a form 
of motor neuron disease. ALS is a progressive, fatal, 
neurodegenerative disease caused by the degeneration 
of motor neurons, the nerve cells in the central ner-
vous system that control voluntary muscle movement. 
Diagnosis is achieved with clinical evaluation, as well 
as electromyography and neuroimaging. However, a 
VLJQL¿FDQWQXPEHURISDWLHQWV DUHPLVGLDJQRVHGRU
diagnosed after a long delay. Therefore, it is crucial 
WR¿QGSRWHQWLDOELRPDUNHUV WR LPSURYHHDUO\ DQG
reliable diagnosis. Using a Bottom-Up analysis and 
LVREDULFTXDQWL¿FDWLRQRIFHUHEURVSLQDOÀXLG &6)
IURP$/6SDWLHQWVZHUHFHQWO\LGHQWL¿HGDSDQHORI
differentially expressed proteins (Borg et. al, submit-
ted). In the present study we applied Top-Down pro-
WHRPLFVWRH[DPLQHPRGL¿FDWLRQVRIWKHVHSURWHLQVLQ
&6)VDPSOHV3RVWWUDQVODWLRQDOPRGL¿FDWLRQV370
and various isoforms of targeted proteins from control 
and sporadic ALS (SALS) were characterized. 
ALS has largely unknown pathogenesis that ty-
pically result in death within a few years from diag-
nosis [1]. There are currently no effective therapies 
for ALS. Clinical diagnosis usually takes several 
months to complete and the long delay between 
symptom onset and diagnosis, limits the possibilities 
for effective intervention and clinical trials [2]. The 
establishment of protein biomarkers for ALS may 
aid an earlier diagnosis, facilitating the search for 
effective therapeutic interventions and monitoring 
GUXJHI¿FDF\GXULQJFOLQLFDOWULDOV
Our goal was to identify by Top-Down proteomics 
PTMs and isoform variants of targeted CSF proteins in 
ALS patients and controls, with the aim of using them 
DVDGLDJQRVLVWRRO:HIRFXVHGRQSURWHLQVZKLFKZHUH
found differentially expressed in our previous studies 
of CSF from ALS patients (Borg et. al, submitted). 
In order to achieve this goal, the following work-
ÀRZZDVDSSOLHG )LJXUH&6)SURWHLQ VDPSOHV
were precipitated with acetonitrile [3] and submit-
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ted to liquid chromatography- mass spectrometry 
(LC-MS) analysis. In detail, Top-Down analysis was 
performed by online LC-nanoESI-MS coupling on a 
/74)78OWUD7KHUPR6FLHQWL¿FZLWKVLPXOWDQHRXV
fraction collection using the Triversa Nanomate (Ad-
YLRQ%LR6FLHQFHV$%LR6XLWHS3KHQ\O:DWHUV
10 µm RPC 2.0 x 75 mm column with a 5-80% ACN 
gradient over 60 min (100 µl/min) was used for intact 
protein separations. A 1/250 part from the column 
eluent was injected directly to the mass spectrome-
ter through the Triversa Nanomate using nanoESI 
chip technology (on line LC-nanoESI-MS, dynamic 
Top-Down) and the rest of the eluent was fraction 
collected in a multi-well plate through the same Na-
nomate.  According to data obtained by dynamic 
7RS'RZQWKHVSHFL¿FUHWHQWLRQWLPHVRIP]LRQV
RILQWHUHVWZHUHYLVXDOL]HGDIWHUZDUGVWKHVHVSHFL¿F
fractions containing ions of interest were infused into 
the MS from the multi-well plate and analyzed by 
static Top-Down. Protein fragments were obtained 
by applying CID or ECD and/or IRMPD on selected 
intact proteins ions according to our interest of iden-
WL¿FDWLRQ370VWXGLHV From 500 to 1000 microscan 
averaging was necessary to increase signal to noise 
ratio (S/N) and obtain informative fragment spectra 
from infused fractions. Obtained data was processed 
E\3URVLJKW3&7KHUPR6FLHQWL¿F
In this work, we focused mainly in 4 proteins na-
med apolipoprotein A1, cystatin C, ȕ-microglobulin 
and ȕ-microglobulin short isoform.
A truncated isoform of apolipoprotein A1 (Apo 
A1) was observed in both control and SALS sam-
ples. An isoform of -128 a.m.u of this truncated 
Apo A1 form was also detected in both samples 
and fragment analysis was consistent with K-10 
deletion (natural variant; K missing in Marburg/
Munster 2 isoform). Short and major isoforms of 
ȕPLFURJOREXOLQZHUH HQFRXQWHUHG6HYHUDO IUDJ-
PHQWV LQGLFDWHG DPRGL¿FDWLRQ RI UHVLGXH DW SR-
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sition 22 (pyroglutamic acid formed from Gln), a 
glycosylation at Ser
4
 or Ser
2
 and a phosphorylation 
in the short isoform. Moreover, further analysis of 
cystatin C protein showed a truncated isoform, an 
oxidation of the Met
14
 and a phosphorylation. Table 
1 summarized PTMs characterized by Top-Down. 
Protein samples collected in multi-well plate at re-
tention times of interest were pooled and digested 
ZLWKVSHFL¿FHQ]\PH7KHVHSHSWLGHVZHUHDQDO\]HG
DSSO\LQJQDQR/&0606DQGWKHLGHQWL¿HGSURWHLQV
FRQ¿UPHGWKHUHVXOWVREWDLQHGE\7RS'RZQ
Figure 1. :RUNÀRZDSSOLHGIRULGHQWL¿FDWLRQDQGFKDUDFWHUL]DWLRQRISRWHQWLDOELRPDUNHVIRU$/6
The isoform variants and PTMs detected in this 
work, showed the potential of Top-Down applied in 
ELRPDUNHU¿HOG1HYHUWKHOHVVWKHVHUHVXOWVPXVWEH
validated in order to use them as a diagnosis tool for 
ALS using and independent methodology.
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Table 1. Summary of the PTMs characterized by Top-Down methodology.
Protein
ret.
times Intact mass**
Major isoform detected
control ALS
PTMs
Apo A1
ß-microglobulin
t, -128.09, missing K
107
 or term Q
truncated Apo A1(t)
t, +162.9, glycation
-17.02, pyro-Glu from Q
-17, +79.96 phosphorylation
-17, +162.05, Glc at S
2/4
truncated cystatin C (t)
t, +15.99, M(O)
t, +79.96, phosphorylation
31.2-31.7
24.8-25.2 13705.91
11741.02
ß-microglobulin
(short isoform)
cystatin C
21.2-21.9
23.5-24.5
30758.93
28061.47
27933.43
28061.40
28224.44
28384.48
13334.48
13350.56
13413.51
13334.48
13350.56
13413.51
11721.78
11801.76
11883.84
11721.78
11801.76
13752.83
13871.82
13928.84
13871.84
13928.86
15789.08
13334.56
27933.43
28061.40
28386.63
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Introduction 
Tissue proteomic studies on atherosclerosis 
have traditionally focused on whole artery extracts 
from biopsy or necropsy origin. Arterial intima and 
media layers are both involved in atherosclerotic 
development. In the present work, we describe an 
optimum method which employs the combination 
of Laser Microdissection and Pressure Catapul-
ting (LMPC) and 2D-DIGE saturation labelling 
to investigate the human intima and media sub-
proteomes isolated from atherosclerotic (coronary 
and aorta) or non-atherosclerotic (preatherosclero-
tic coronary) arteries.
Methods
Coronary biopsies from patients undergoing 
bypass surgery and coronary and aorta necropsies 
were immediately washed in saline and freezed em-
bedded with OCT. Intima and media were isolated 
by LMPC with a Microbeam System (PALM Micro-
laser). Several methods for staining (hematoxilin, 
cresyl violet), protein extraction and DIGE labelling 
were tested in order to achieve the better protocol 
Optimum method designed for 2D-DIGE of arterial intima and media isolated 
by laser microdissection
Fernando de la Cuesta1, Gloria Álvarez-Llamas1, Irene Zubiri1,  Aroa Sanz-Maroto1, Alicia Donado2,
Luis Rodríguez-Padial4, Ángel García-Pinto2, María González-Barderas*5, Fernando Vivanco1,6
1Department of Immunology. Fundación Jiménez Díaz, Madrid, Spain. 2Cardiac Surgery Unit. Hospital 
Gregorio Marañon, Madrid, Spain. 3Department of Pathology. Hospital Virgen de la Salud, Toledo, Spain. 
4Department of Cardiology. Hospital Virgen de la Salud, Toledo, Spain. 5Department of Vascular Physio-
pathology. Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain. 6Department of Biochemistry and 
Molecular Biology I, Universidad Complutense, Madrid, Spain.
for 2-DE analysis of human arterial layers. First of 
all, a spin column chromatographic step with Pro-
tein Desalting Spin Columns (Pierce) was assayed 
in order to minimize negative effects from remai-
ning stain. In addition, different lysis buffers were 
WHVWHGWRDVVXUHHI¿FLHQWH[WUDFWLRQRIDUWHULDOOD\HUV
proteome, which is problematic due to highly acidic 
P\R¿ODPHQWSURWHLQVDQGSUHVHQFHRIFDOFLXP
Results
Concerning staining methods, both hematoxilin 
and cresyl violet were found to negatively affect 
protein extraction and IEF. A chromatographic spin 
column step prior to saturation DIGE labelling im-
proved substantially 2-DE gels, permitting the use 
of both stains for human arterial layers proteomic 
analysis. Ethanol solved cresyl violet minimizes 
proteases action and facilitates visualization of arte-
rial tissue. For this reasons this stain was chosen for 
further analysis. Optimal DIGE labelling conditions 
were set at 1nmol TCEP and 2nmol Dye, so that free 
dye deleterious effects were minimized. The addi-
tion of SDS, and in a higher extend DTT, on lysis 
EXIIHUVLJQL¿FDQWO\LQFUHDVHGSURWHLQVROXELOL]DWLRQ
